<table id="id_7d85712e-99f9-4d4e-b1ec-222b78b2a91b" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_3e6a26fe-0228-4bcb-937d-4f069269c902">Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#i4i_section_ID_s2.6">2.6</linkhtml>, <linkhtml href="#i4i_section_ID_s5.1">5.1</linkhtml>, <linkhtml href="#i4i_interactions_ID_s7">7</linkhtml>, <linkhtml href="#i4i_pharmacokinetics_ID_s12.3">12.3</linkhtml>)</caption>
<col align="left" width="50%"></col>
<col align="left" width="50%"></col>
<tbody>
<tr id="id_6c6ee30a-ef90-4cd5-831b-7c0427c5c9f8" stylecode="Toprule">
<td align="left" stylecode="Rrule" valign="top">Interacting Agents </td>
<td align="left" valign="top">Prescribing Recommendations </td>
</tr>
<tr id="id_9b457b1f-2a89-41ee-8f60-82bee6cfe81f">
<td align="left" stylecode="Rrule" valign="top">Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir)</td>
<td align="left" valign="middle">Avoid atorvastatin</td>
</tr>
<tr id="id_269bb023-5cc0-4d90-9c7a-130de44b54dc">
<td align="left" stylecode="Rrule" valign="top">HIV protease inhibitor (lopinavir plus ritonavir)</td>
<td align="left" valign="middle">Use with caution and lowest dose necessary</td>
</tr>
<tr id="id_27262d3f-e429-459a-8a9a-a27ad296d58b">
<td align="left" stylecode="Rrule" valign="top">Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir)</td>
<td align="left" valign="middle">Do not exceed 20 mg atorvastatin daily</td>
</tr>
<tr id="id_e9daf57d-b301-4e87-bd9d-4dcc086e8e7a" stylecode="Botrule">
<td align="left" stylecode="Rrule" valign="middle">HIV protease inhibitor (nelfinavir)<br/>Hepatitis C protease inhibitor (boceprevir)</td>
<td align="left" valign="middle">Do not exceed 40 mg atorvastatin daily</td>
</tr>
</tbody>
</table>